Pfizer Inc Stock Buy Hold or Sell Recommendation

PFE Stock  USD 27.78  0.19  0.69%   
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Pfizer Inc is 'Strong Hold'. Macroaxis provides Pfizer buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Pfizer positions. The advice algorithm takes into account all of Pfizer's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Pfizer's buy or sell advice are summarized below:
Real Value
33.18
Target Price
38.67
Hype Value
27.79
Market Value
27.78
Naive Value
27.68
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Pfizer Inc given historical horizon and risk tolerance towards Pfizer. When Macroaxis issues a 'buy' or 'sell' recommendation for Pfizer Inc, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Pfizer Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Pfizer and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Pfizer Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.

Execute Pfizer Buy or Sell Advice

The Pfizer recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Pfizer Inc. Macroaxis does not own or have any residual interests in Pfizer Inc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Pfizer's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell PfizerBuy Pfizer
Strong Hold

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Below AverageDetails

Economic Sensitivity

Follows the market closelyDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

HealthyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Pfizer Inc has a Risk Adjusted Performance of 0.0073, Jensen Alpha of (0.09), Total Risk Alpha of (0.31), Sortino Ratio of (0.1) and Treynor Ratio of (0.01)
Our recommendation module complements current analysts and expert consensus on Pfizer. It analyzes the company potential to grow using all fundamental, technical, and market related data available at the time. To make sure Pfizer is not overpriced, please check all Pfizer Inc fundamentals, including its cash and equivalents, earnings per share, and the relationship between the revenue and current ratio . Given that Pfizer Inc has a price to book of 1.76 X, we recommend you to check out Pfizer Inc market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Pfizer Trading Alerts and Improvement Suggestions

Pfizer Inc generated a negative expected return over the last 90 days
About 70.0% of the company shares are owned by institutional investors
On 1st of March 2024 Pfizer paid $ 0.42 per share dividend to its current shareholders
Latest headline from pymnts.com: Adobe Adds GenAI-Powered Workflow Planning to Content Supply Chain

Pfizer Returns Distribution Density

The distribution of Pfizer's historical returns is an attempt to chart the uncertainty of Pfizer's future price movements. The chart of the probability distribution of Pfizer daily returns describes the distribution of returns around its average expected value. We use Pfizer Inc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Pfizer returns is essential to provide solid investment advice for Pfizer.
Mean Return
0
Value At Risk
-2.09
Potential Upside
3.28
Standard Deviation
1.38
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Pfizer historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Pfizer Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Pfizer is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pfizer Inc backward and forwards among themselves. Pfizer's institutional investor refers to the entity that pools money to purchase Pfizer's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
State Farm Mutual Automobile Ins Co2023-12-31
54.5 M
Legal & General Group Plc2023-12-31
49.6 M
Goldman Sachs Group Inc2023-12-31
48.1 M
Bank Of America Corp2023-12-31
47.9 M
Bank Of New York Mellon Corp2023-12-31
44.1 M
Amundi2023-12-31
42.6 M
Jpmorgan Chase & Co2023-12-31
42.4 M
Dimensional Fund Advisors, Inc.2023-12-31
42 M
Deutsche Bank Ag2023-12-31
40.2 M
Vanguard Group Inc2023-12-31
506.5 M
Blackrock Inc2023-12-31
432.5 M
Note, although Pfizer's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Pfizer Cash Flow Accounts

201920202021202220232024 (projected)
Change To Inventory(1.1B)(736M)(1.1B)592M(1.2B)(1.1B)
Change In Cash125M475M158M(1.5B)2.4B2.6B
Free Cash Flow10.0B11.6B29.9B26.0B4.8B4.6B
Depreciation6.0B4.8B5.2B5.1B6.3B4.1B
Other Non Cash Items(7.0B)3.6B(4.8B)150M5.4B5.6B
Dividends Paid8.0B8.4B8.7B9.0B(9.2B)(8.8B)
Capital Expenditures2.6B2.8B2.7B3.2B3.9B4.1B
Net Income16.3B7.0B22.5B31.4B2.1B2.0B
End Period Cash Flow1.4B1.8B2.0B468M2.9B2.2B
Change To Netincome2.9B2.9B(7.3B)(2.7B)(2.5B)(2.3B)
Investments9.3B(2.6B)(19.5B)11.1B(32.3B)(30.7B)
Change Receivables(742M)(1.2B)(3.8B)261M234.9M246.6M
Net Borrowings8.8B(12.8B)(1.1B)(3.5B)(3.2B)(3.0B)

Pfizer Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Pfizer or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Pfizer's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Pfizer stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-0.09
β
Beta against NYSE Composite0.68
σ
Overall volatility
1.43
Ir
Information ratio -0.1

Pfizer Volatility Alert

Pfizer Inc has relatively low volatility with skewness of 0.91 and kurtosis of 2.14. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Pfizer's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Pfizer's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Pfizer Implied Volatility

Pfizer's implied volatility exposes the market's sentiment of Pfizer Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Pfizer's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Pfizer stock will not fluctuate a lot when Pfizer's options are near their expiration.

Pfizer Fundamentals Vs Peers

Comparing Pfizer's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Pfizer's direct or indirect competition across all of the common fundamentals between Pfizer and the related equities. This way, we can detect undervalued stocks with similar characteristics as Pfizer or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Pfizer's fundamental indicators could also be used in its relative valuation, which is a method of valuing Pfizer by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Pfizer to competition
FundamentalsPfizerPeer Average
Return On Equity0.0235-0.31
Return On Asset0.0155-0.14
Profit Margin0.04 %(1.27) %
Operating Margin(0.50) %(5.51) %
Current Valuation214.38 B16.62 B
Shares Outstanding5.66 B571.82 M
Shares Owned By Insiders0.04 %10.09 %
Shares Owned By Institutions69.96 %39.21 %
Number Of Shares Shorted66.12 M4.71 M
Price To Earning9.48 X28.72 X
Price To Book1.76 X9.51 X
Price To Sales2.69 X11.42 X
Revenue58.5 B9.43 B
Gross Profit66.23 B27.38 B
EBITDA10.53 B3.9 B
Net Income2.13 B570.98 M
Cash And Equivalents2.85 B2.7 B
Cash Per Share6.44 X5.01 X
Total Debt75.04 B5.32 B
Debt To Equity0.40 %48.70 %
Current Ratio1.59 X2.16 X
Book Value Per Share15.77 X1.93 K
Cash Flow From Operations8.7 B971.22 M
Short Ratio1.53 X4.00 X
Earnings Per Share0.37 X3.12 X
Price To Earnings To Growth0.28 X4.89 X
Target Price32.18
Number Of Employees88 K18.84 K
Beta0.56-0.15
Market Capitalization157.22 B19.03 B
Total Asset226.5 B29.47 B
Retained Earnings118.35 B9.33 B
Working Capital(4.46 B)1.48 B
Note: Acquisition by John Young of tradable shares of Pfizer subject to Rule 16b-3 [view details]

Pfizer Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Pfizer . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Pfizer Buy or Sell Advice

When is the right time to buy or sell Pfizer Inc? Buying financial instruments such as Pfizer Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total37.0B34.9B75.0B78.8B
Total Assets181.5B197.2B226.5B237.8B

Use Investing Ideas to Build Portfolios

In addition to having Pfizer in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Consumption Thematic Idea Now

Consumption
Consumption Theme
Companies that deliver final goods such as cars or clothing for consumption by consumers. The Consumption theme has 18 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumption Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:
Check out Pfizer Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Pfizer Stock analysis

When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.76)
Dividend Share
1.64
Earnings Share
0.37
Revenue Per Share
10.366
Quarterly Revenue Growth
(0.41)
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.